Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Barclays PLC Discloses 8.05% Stake in Bluerock Acquisition Corp. II Units

Barclays PLC filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 1,207,500 units of Bluerock Acquisition Corp. II, a special purpose acquisition company headquartered at 919 Third Avenue, New York, NY 10022.

Vinay Lochav | 06 November 2026

Van Den Heuvel Exercises 17,479 CINF Options, Nov 2026

Will H. Van Den Heuvel, Executive Vice President of Cincinnati Financial Corp, filed a Form 4 on November 5, 2026, reporting transactions in Cincinnati Financial common stock dated November 4, 2026, on NASDAQ:CINF.

Vinay Lochav | 06 November 2026

Barclays PLC Discloses 6.99% Stake in Cannae Holdings

Barclays PLC filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 3,034,244 shares of Cannae Holdings Inc common stock as of September 30, 2026.

Vinay Lochav | 06 November 2026

Braveheart Bio Presents 52-Week HRS/BHB-1893 Data at AHA 2026

Braveheart Bio, Inc. filed a Form 8-K on November 6, 2026, disclosing that the company and Hengrui Pharma presented data from a 52-week open-label extension of a Phase 2 study of HRS/BHB-1893 in obstructive hypertrophic cardiomyopathy at the American Heart Association Scientific Sessions 2026.

Nitish Kishor | 06 November 2026

Lotfi Grants 11,100 CVD Equipment Shares at 2026 Annual Meeting

Director Ashraf Wagih Lotfi filed a Form 4 with the SEC on November 6, 2026, disclosing an automatic grant of 11,100 shares of CVD Equipment Corp common stock received on November 5, 2026, under the company's Director Compensation Plan.

Anjali Anand | 06 November 2026

Actuate Therapeutics (NASDAQ:ACTU) Trading Near All-Time Low: Shares Down 5%, Elraglusib Program and Nasdaq Notice in Focus

The company is developing elraglusib, a small molecule designed to enter cancer cells and block the enzyme glycogen synthase kinase-3 beta. It has not generatedRevenuefrom product sales since its inception, according to its quarterly report.

Nitish Kishor | 06 November 2026

Addentax Group (NASDAQ:ATXG) Trading Near All-Time Low: Shares Up 8%, Fiscal First Quarter Revenue and Net Income in Focus

Addentax is a NevadaHolding Companythat conducts its operations through subsidiaries in the PRC. The group is engaged in garment manufacturing, logistics services, consulting services and financing services.

Nitish Kishor | 06 November 2026

ADTRAN (NASDAQ:ADTN) Trading Near All-Time Low: Shares Down 3%, Fourth Quarter Outlook and Credit Facility in Focus

ADTRAN provides networking and communications platforms, software, systems and services for carrier networks,Data Centerinterconnect for private enterprise networks and mission critical infrastructure. Its global headquarters are in Huntsville, Alabama, and its European headquarters are in Munich, Germany. It reports two segments, Network Solutions and …

Nitish Kishor | 06 November 2026

AEVEX (NYSE:AVEX) Trading Near All-Time Low: Shares Up 10%, Second Quarter Profit and IPO Proceeds in Focus

AEVEX describes itself as a defense technology prime contractor and an enabler of U.S. unmanned systems missions, including precision strike launched effects, loitering munitions and intelligence, surveillance and reconnaissance. It reports through two segments, Tactical Systems and Global Solutions.

Nitish Kishor | 06 November 2026

AIAI Holdings (NASDAQ:AIAI) Trading Near All-Time Low: Shares Down 4%, Acquisitions and Successor Period Results in Focus

The company was formed as a Delaware corporation on July 19, 2024 to complete a direct listing and to build an AI-powered ecosystem by acquiring and integrating businesses. It had 70,662,761 shares of common stock outstanding as of August 11, 2026.

Nitish Kishor | 06 November 2026
Support

Hi! How can we help you today?

Loading…